Jiangsu Jibeier Pharmaceutical Hits Day Low Amid Price Pressure at CNY 27.98

Jiangsu Jibeier Pharmaceutical Co. experienced a notable decline today, with the stock dropping by 5.27% on March 23, 2026. The stock reached an intraday low of CNY 27.98, reflecting a challenging trading environment for the mid-cap pharmaceutical company. In terms of performance metrics, Jiangsu Jibeier's one-week performance stands at -7.7%, while its one-month performance shows a decrease of 4.1%. Over the past year, however, the company has managed to achieve a positive return of 22.27%, outperforming the China Shanghai Composite, which recorded a gain of 13.33%. Year-to-date, Jiangsu Jibeier has seen a decline of 6.0%, compared to the composite's drop of 3.92%. Financially, the company has a market capitalization of CNY 4,930 million and a price-to-earnings ratio of 29.00. The dividend yield is currently at 1.97%, and the return on equity is reported at 10.20%. Despite these figures, the company faces challenges, including a high debt-equity ratio of -0.37 and a low debtors turnover ratio of 2.72 times.